Flash Therapeutics, LLC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Flash Therapeutics, LLC - overview
Location
Boston, MA, US
Primary Industry
Biotechnology
About
Based in Massachusetts, US, Flash Therapeutics, LLC is a biotechnology company that focuses on developing an oral compound to prevent acute myeloid leukemia (AML) relapse. The company's team members have work experience in Merck, Bristol-Myers Squibb, Novartis, and Takeda, and have decades of drug-hunting experience. And the company team members have clinical experience when they worked in cancer research institutions and would access patient-derived tumor biology and ground-breaking research. The company has developed candidate oral drugs to prevent AML relapse, using novel findings linking Hematopoietic Cell Kinase (HCK) to AML.
The HCK is a potential therapeutic target for leukemic cells. The company has identified five potential compounds for further testing. One is moving on to IND filing while the other four are going to begin animal toxicology testing.
Current Investors
JMCR Family Office, Viva Ventures Biotech, Viva BioInnovator
Primary Industry
Biotechnology
Sub Industries
Biotechnology, Healthcare, Healthcare Specialists, Pharmaceuticals, Molecular Chemicals
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.